logo

For the Inventor, By the Inventor

Tone, Japan

Tatsuhiko Katori

This inventor holds 21 USPTO granted patents. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1986-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuhiko Katori. Retrieved from https://idiyas.com/inventor/tatsuhiko-katori

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 130(Granted Patents)


Location History:

  • Tonemachi, JP (1987)
  • Ibaragi, JP (1987 - 1988)
  • Ibaraki, JP (1990 - 1992)
  • Tone, JP (1986 - 1994)

Company Filing History:

goldMedal21 out of 90 
 
Ss Pharmaceutical Co., Ltd.
 patents

Years Active: 1986-1994

Loading Chart...
21 patents (USPTO):Explore Patents
1. 5324735 - Quinoline carboxylic acid derivatives (1994-06-28),
2. 5082948 - Imidazole derivative (1992-01-21),
3. 5047428 - Expectorant comprising hydroxyalkylcysteine derivative (1991-09-10),
4. 5008419 - Novel platinum complex (1991-04-16),
5. 4977275 - Pyrrole derivatives (1990-12-11),
6. 4968825 - Novel platinum complex (1990-11-06),
7. 4942172 - Method of curing hepatic disease (1990-07-17),
8. 4933447 - Quinoline derivatives (1990-06-12),
9. 4925953 - Imidazole derivative (1990-05-15),
10. 4906665 - Hydroxyalkylcysteine derivative and expectorant containing the same (1990-03-06),
11. 4904809 - Platinum complex (1990-02-27),
12. 4876359 - Novel gamma-butyrolactone derivatives (1989-10-24),
13. 4866176 - 8-Piperazinyl-1,7-naphthyridine derivative having pharmaceutical activity (1989-09-12),
14. 4849512 - 3-acylamino-3-deoxyallose derivatives (1989-07-18),
15. 4814436 - Derivative of .alpha., .alpha.-trehalose and a process for preparing the (1989-03-21),

Title: Tatsuhiko Katori: Pioneering Innovations in Antimicrobial Agents

Introduction:

Tatsuhiko Katori is a distinguished inventor hailing from Tone, Japan. With a remarkable portfolio of 21 patents, he has made significant contributions to the field of pharmaceuticals and antimicrobial agents.

Latest Patents:

Among his latest patents are groundbreaking inventions such as Quinoline carboxylic acid derivatives, Imidazole derivative, and Novel imidazole derivatives known for their strong antimicrobial activity. These inventions have proven effective against various fungi and Gram-positive bacteria, showcasing Katori's commitment to advancing healthcare solutions.

Career Highlights:

Katori's innovative spirit shines through his work at Ss Pharmaceutical Co., Ltd., where he continues to push boundaries in pharmaceutical research and development. His dedication to creating novel antimicrobial agents has earned him recognition as a leading figure in the industry.

Collaborations:

Throughout his career, Katori has collaborated closely with esteemed colleagues such as Hideaki Matsuda and Susumu Sato. Together, they have fostered a culture of innovation and excellence, driving forward groundbreaking research initiatives that have the potential to impact global health outcomes.

Conclusion:

In conclusion, Tatsuhiko Katori stands as a shining example of ingenuity and perseverance in the world of invention. His legacy continues to inspire future generations of innovators, leaving an indelible mark on the field of pharmaceuticals and antimicrobial research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…